These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6255658

  • 1. Male climacteric after orchiectomy in patient with prostatic cancer.
    Steinfeld AD, Reinhardt C.
    Urology; 1980 Dec; 16(6):620-2. PubMed ID: 6255658
    [Abstract] [Full Text] [Related]

  • 2. Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer.
    Shearer RJ, Hendry WF, Sommerville IF, Fergusson JD.
    Br J Urol; 1973 Dec; 45(6):668-77. PubMed ID: 4359746
    [No Abstract] [Full Text] [Related]

  • 3. [Hormonal adaptation in the climacteric and the question of hormone therapy in postmenopause].
    Kyank H.
    Z Alternsforsch; 1966 Dec; 19(3):305-16. PubMed ID: 4294394
    [No Abstract] [Full Text] [Related]

  • 4. [FSH, LH, estradiol and testosterone levels after Seda-Presomen in women following hysterectomy with bilateral adnexotomy].
    Stehlíková J, Heczko P, Talas M, Janousková M.
    Acta Univ Palacki Olomuc Fac Med; 1981 Dec; 101():139-45. PubMed ID: 6100769
    [No Abstract] [Full Text] [Related]

  • 5. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE, Welch MJ, Schmidt JD, Culp DA, Flocks RH.
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract] [Full Text] [Related]

  • 6. The time for serum testosterone to reach castrate level after bilateral orchiectomy or oral estrogen in the management of metastatic prostatic cancer.
    Lin BJ, Chen KK, Chen MT, Chang LS.
    Urology; 1994 Jun; 43(6):834-7. PubMed ID: 8197647
    [Abstract] [Full Text] [Related]

  • 7. Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer.
    Miller JI, Ahmann FR.
    Urology; 1992 Dec; 40(6):499-502. PubMed ID: 1281587
    [Abstract] [Full Text] [Related]

  • 8. A NEW PITUITARY-INHIBITING COMPOUND IN THE TREATMENT OF PROSTATIC CANCER.
    NYLANDER G, TERNER N.
    Urol Int; 1964 Dec; 17():129-45. PubMed ID: 14168016
    [No Abstract] [Full Text] [Related]

  • 9. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma.
    Sinha AA, Blackard CE, Seal US.
    Cancer; 1977 Dec; 40(6):2836-50. PubMed ID: 201356
    [No Abstract] [Full Text] [Related]

  • 10. Ureteral obstruction in the patient with prostatic carcinoma.
    Marks LS, Gallo DA.
    Br J Urol; 1972 Aug; 44(4):411-6. PubMed ID: 5070145
    [No Abstract] [Full Text] [Related]

  • 11. Diethylstilbestrol in treatment of postorchiectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone.
    Atala A, Amin M, Harty JI.
    Urology; 1992 Feb; 39(2):108-10. PubMed ID: 1736500
    [Abstract] [Full Text] [Related]

  • 12. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE, Byar DP, Jordan WP.
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract] [Full Text] [Related]

  • 13. Simultaneous endocrine management and chemotherapy as initial treatment in M1 prostatic carcinoma.
    Richards B.
    Prog Clin Biol Res; 1988 Jun; 269():177-86. PubMed ID: 2839846
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of prostatic bleeding: suppression of angiogenesis by androgen deprivation.
    Marshall S, Narayan P.
    J Urol; 1993 Jun; 149(6):1553-4. PubMed ID: 7684792
    [Abstract] [Full Text] [Related]

  • 15. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S, Collins WP, Thom MH, Studd JW.
    Br Med J; 1979 Apr 14; 1(6169):983-5. PubMed ID: 219937
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
    Eisenberger MA, O'Dwyer PJ, Friedman MA.
    J Clin Oncol; 1986 Mar 14; 4(3):414-24. PubMed ID: 2936872
    [Abstract] [Full Text] [Related]

  • 17. Biochemical endocrinology of prostatic tumors.
    Voigt KD, Krieg M.
    Curr Top Exp Endocrinol; 1978 Mar 14; 3():173-99. PubMed ID: 77753
    [No Abstract] [Full Text] [Related]

  • 18. Carcinoma of prostate. Long-term survival after bilateral adrenalectomy.
    Merrin C, Murphy GP, Chu TM, Mittleman A.
    Urology; 1974 Feb 14; 3(2):223-5. PubMed ID: 4812670
    [No Abstract] [Full Text] [Related]

  • 19. Plasma testosterone in patients receiving diethylstilbestrol.
    Beck PH, McAnich JW, Goebel JL, Stutzman RE.
    Urology; 1978 Feb 14; 11(2):157-60. PubMed ID: 628992
    [Abstract] [Full Text] [Related]

  • 20. [Endocrine findings during hormonal treatment of metastasizing prostatic carcinoma].
    Krause W, Weidner W, Rothauge CF.
    Urol Int; 1982 Feb 14; 37(6):400-9. PubMed ID: 6891127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.